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Abstract 
Background: Clinical mastitis is an inflammation of the mammary gland and causes significant costs to dairy 
production. It is unfavourably genetically correlated to milk production, and, thus, knowledge of the mechanisms 
that underlie these traits would be valuable to improve both of them simultaneously through breeding. A quantita‑
tive trait locus (QTL) that affects both clinical mastitis and milk production has recently been fine‑mapped to around 
89 Mb on bovine chromosome 6 (BTA6), but identification of the gene that underlies this QTL was not possible due to 
the strong linkage disequilibrium between single nucleotide polymorphisms (SNPs) within this region. Our aim was 
to identify the gene and, if possible, the causal polymorphism(s) responsible for this QTL through association analysis 
of high‑density SNPs and imputed full sequence data in combination with analyses of transcript and protein levels of 
the identified candidate gene.
Results: Associations between SNPs and the studied traits were strongest for SNPs that were located within and 
immediately upstream of the group‑specific component (GC) gene. This gene encodes the vitamin D‑binding protein 
(DBP) and has multiple roles in immune defense and milk production. A 12‑kb duplication that was identified down‑
stream of this gene covered its last exon and segregated with the QTL allele that is associated with increased mastitis 
susceptibility and milk production. However, analyses of GC mRNA levels on the available samples revealed no differ‑
ences in expression between animals having or lacking this duplication. Moreover, we detected no differences in the 
concentrations of DBP and its ligand vitamin D between the animals with different GC genotypes that were available 
for this study.
Conclusions: Our results suggest GC as the gene that underlies the QTL for clinical mastitis and milk production. 
However, since only healthy animals were sampled for transcription and expression analyses, we could not draw any 
final conclusion on the absence of quantitative differences between animals with different genotypes. Future studies 
should investigate GC RNA expression and protein levels in cows with different genotypes during an infection.
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Background
Clinical mastitis (CM) is an inflammation of the mam-
mary gland, which is generally caused by the intro-
duction and multiplication of microorganisms. The 
consequences of CM include reduced animal welfare, 
economic losses due to reduced milk yield and altered 
milk composition, increased costs due to veterinary 
treatment of diseased animals, increased use of antibi-
otics, and early culling of animals. Thus, there is a high 
demand for solutions that help reduce the incidence 
of mastitis. Genetic improvement of resistance to CM 
by traditional breeding is possible [1], in spite of its 
low heritability [2] and an unfavorable genetic correla-
tion with milk production (ranging from 0.21 to 0.55 in 
Norwegian Red; [3]). Knowledge of the genetic mecha-
nisms that are involved both in susceptibility to mastitis 
and in milk production would be valuable information 
for selection programs to break the genetic correlation 
between these traits and improve both traits simultane-
ously. One approach to gain such knowledge is to iden-
tify associations between high-density or sequence level 
single nucleotide polymorphisms (SNPs) and the traits 
in question.
A quantitative trait locus (QTL) that affects susceptibil-
ity to CM or somatic cell score, which is an indicator trait 
of CM, was reported at ~90 Mb on bovine chromosome 6 
(BTA6) in Norwegian Red cattle (NR) [4, 5] and in several 
Holstein populations [6–8]. Several genes that are known 
to be involved in immune defense, such as those that 
encode the CXC chemokines and are located at around 
90.6  Mb, and the IGJ gene at 87.8  Mb that encodes the 
immunoglobulin J polypeptide, have been suggested as 
candidates for susceptibility to mastitis [5, 7]. However, 
two recent publications suggested that the gene group-
specific component (GC) at 88.7 Mb was responsible for 
both a QTL that affects CM [9] and a QTL for milk pro-
duction [10]. In both studies, the high level of linkage 
disequilibrium (LD) within this QTL region limited the 
ability to identify the causal polymorphisms.
Group-specific component is a logical functional and 
positional candidate gene. It is mainly transcribed in the 
liver [11] and encodes the vitamin D-binding protein 
(DBP), which circulates in blood and has multiple impor-
tant roles in the immune system and host defense, e.g. 
as the main carrier of vitamin D. DBP has also been sug-
gested to have a direct role on milk production [10].
In this study, we performed association analyses on 
high-density SNP chips and imputed full sequence data 
in order to identify the gene, and if possible the polymor-
phism (or polymorphisms) on BTA6 behind the variation 
in susceptibility to CM and in milk production. We also 
studied splice variants and determined the transcript lev-
els of the identified gene in liver samples, and analyzed 
the concentrations of DBP and its ligand in serum sam-
ples from individuals with different GC genotypes.
Methods
Biological samples
Three different sets of samples were used:
(A)  Semen samples from Norwegian Red artificial 
insemination (AI) bulls for which phenotypic 
information was available for SNP genotyping 
(the number of bulls varied among analyses as 
described in the relevant sections), and semen 
samples from NR bulls and blood samples from 
NR cows for genome resequencing.
(B)  Liver samples from 112 healthy NR animals, 
mostly bulls, from which DNA was extracted for 
SNP genotyping; 10 of these 112 individuals were 
selected for analysis of mRNA expression.
(C)  Blood serum samples from 50 healthy NR cows, 
of which 21 were pregnant at the time of sam-
pling, for analysis of protein expression and vita-
min D levels.
DNA and RNA isolation
DNA was extracted from semen and blood using stand-
ard protocols. Liver samples were collected post-mortem 
during two consecutive days at one specific abattoir at 
approximately the same time after culling of each indi-
vidual. Slaughter started in the morning and all sampled 
animals were culled within 2.5 h. Data from the Norwe-
gian Health Card system showed that all animals were 
healthy. All animals were between 512 and 628 days old 
at the time of the sampling. DNA from the liver samples 
was extracted (NucleoSpin Tissue kit, Macherey–Nagel, 
Hoerdt) and then used for genotyping with the SNP 
that was most strongly associated with CM and with the 
detected duplication.
Based on the genotypes for rs110675140, liver sam-
ples from ten unrelated bulls (five for each homozygous 
genotype) from randomly selected farms (in order to 
randomize the environmental effect) were selected and 
used for analysis of mRNA expression. RNA was iso-
lated by using the QIAzol lysis reagent (Qiagen, Hilden, 
Germany) and on-column purification NucleoSpin RNA 
kit (Macherey–Nagel) with on-column DNase diges-
tion according to the manufacturer’s instructions. RNA 
concentration and quality were measured with a Nan-
oDrop 1000 spectrophotometer (Thermo Fisher Scien-
tific, Wilmington) and Agilent RNA 6000 Nano LabChip 
on the 2100 Agilent BioAnalyzer (Agilent Technologies, 
Palo Alto), respectively. All samples had an RNA integrity 
number (RIN) between 7 and 8 and an OD A260/A280 
ratio of approximately 2.
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Preparation of serum samples
Sampling of blood for serum analysis was performed 
by a certified veterinarian and thus conducted in agree-
ment with the provisions enforced by the Norwegian 
Animal Research Authority. More details about the 
tested animals are in Additional file  1: Table S1. Blood 
was collected in 10 mL collection tubes (BD Vacutainer® 
Plus Plastic Serum Tubes, Becton, Dickinson and Com-
pany, Franklin Lakes), using three tubes per animal. The 
samples were allowed to clot at room temperature for 
approximately 30  to  60  min, prior to centrifugation at 
2000g (10 min, 4 °C). The serum was immediately trans-
ferred into a new tube and stored at −20 °C until analysis.
Traits
Daughter yield deviations (DYD) for seven CM traits and 
five milk production traits were derived for AI bulls using 
solutions from the national genetic evaluation of the NR 
population that is carried out by GENO Breeding and AI 
Association.
In the routine genetic evaluation of CM, records on 
the veterinary treatments applied to treat CM are used 
to define seven binary traits, each of these indicating the 
occurrence of CM in one of seven time intervals. These 
time intervals include three periods during the first 
lactation: CM1 [−15 to 30  d postpartum (dpp)], CM2 
(31 to 120 dpp) and CM3 (121 to 305 dpp), two periods 
during the second lactation: CM4 (−15 to 30 dpp) and 
CM5 (31  to 120 dpp); and two periods during the third 
lactation: CM6 (−15 to 30 dpp) and CM7 (31 to 120 dpp).
Five milk production traits, i.e., 305 d lactation yields 
for kg milk, kg protein, kg fat, protein percentage and 
fat percentage, were based on monthly test-day records 
of milk yield and bimonthly records of kg fat and kg pro-
tein. Animal repeatability models that were based on data 
from the first to third lactation were used for the genetic 
evaluation of milk production traits.
The number of bulls with trait data varied for each trait, 
especially in the case of CM traits because many cows 
were culled before they reached the last period of the last 
lactation. In addition, selection of animals for genotyp-
ing was performed to fit the needs of several studies, and 
hence the number of bulls with both trait and genotype 
data varied among analyses as described below.
Construction of a high‑density SNP dataset for BTA6
Genotypes from the Affymetrix 25K SNP array (Affym-
etrix, Santa Clara), the Illumina BovineSNP50 BeadChip 
(54K) and the Illumina BovineHD Genotyping BeadChip 
(777K) (Illumina, San Diego) were combined to produce 
a dataset for BTA6 that consisted of 26,737 SNPs. First, 
2552 NR AI bulls were genotyped on the 25K chip. Then, 
1575 NR bulls were genotyped on the 54K chip with 536 
of these 1575 animals already genotyped on the 25K chip. 
Finally, 384 of the 1575 bulls were genotyped on the 777K 
chip. The three datasets were filtered to remove SNPs 
with a minor allele frequency lower than 0.05. Map posi-
tions were based on the bovine reference genome assem-
bly (UMD 3.1; [12]). SNPs on unplaced scaffolds and on 
sex chromosomes were discarded. The 25K dataset was 
imputed to 54K and then the combined 54K dataset 
was imputed to 777K. All imputations and phasing of 
data were completed using BEAGLE v3.3.1 [13]. Phasing 
information was used to identify double recombinants, 
i.e. a heterozygous genotype with a phase that differed 
from the phase on both sides. Such genotypes were either 
corrected (for instance from AG to GA) or removed. All 
five milk traits and seven CM traits were analyzed for 
these 26,737 SNPs on BTA6. There were 3090 bulls with 
genotype data and DYD information for the five milk 
traits, CM1 and CM2, and this number decreased with 
later CM periods to 2874 bulls for CM7.
Genome sequencing, alignment of sequence reads 
and variant calling
Whole-genome sequencing data were obtained for 
147 animals at three different time points in batches of 
5, 16 and 126 animals. A first batch of five bulls were 
sequenced by FASTERIS (Switzerland) on an Illumina 
Genome Analyzer GAIIx instrument (Illumina, San 
Diego, CA, USA) with 2 × 108 bp paired end reads. The 
TruSeq SBS V2-GA kit was used to prepare libraries and 
the FASTX-toolkit v0.0.13 (Hannon Lab, FASTX-Toolkit, 
0.0.13 ed2010) for adaptor- and quality-trimming of 
raw reads in FASTQ-format. An average sequence cov-
erage of ~4× and 10× was obtained for three and two 
bulls, respectively. A second batch of 16 elite bulls were 
sequenced by AROS (Denmark) on a HiSeq 2000 plat-
form according to the manufacturer’s protocols. Samples 
were prepared for paired-end sequencing (2  ×  100  bp) 
using the TruSeq kit and sequenced with the Illumina V3 
kit (Illumina, San Diego) to generate an average cover-
age of 10×. Finally, the third batch that included 96 NR 
elite bulls and 31 NR cows were sequenced by the Nor-
wegian Sequencing Centre (http://www.sequencing.uio.
no) on a HiSeq 2500 platform according to the manu-
facturer’s protocols. Samples were prepared for paired-
end sequencing (2 × 125 bp) by using the TruSeq DNA 
PCR-free library preparation kits and sequenced with 
the Illumina V4 kit (Illumina, San Diego) to generate an 
average coverage of 9×. Average sequencing coverage in 
a 1-Mb region that included the most significant markers 
and the duplication agreed with the genome-wide aver-
age coverage.
The quality of the Illumina reads was checked with 
fastQC [14]. Adaptors were trimmed as described above 
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but no quality trimming of the Illumina reads was done 
before alignment, as recommended when the read qual-
ity is sufficiently high (all samples had mean PHRED 
quality scores above 30 throughout the whole length of 
the reads). All reads were aligned against the UMD 3.1 
bovine genome assembly using BWA-mem version 0.7.10 
[15] and then PCR duplicates were sorted and marked 
and the resulting SAM files were indexed using SAM-
tools version 1.2 [16]. Between 98.7 and 99.6  % of the 
reads were mapped to the reference genome, including all 
chromosomes and unplaced scaffolds. Variant calling was 
done with FreeBayes version 1.0.2 [17], with a minimum 
total read coverage of 10, a minimum PHRED-based 
mapping score of 20 and a minimum PHRED-based base 
quality of 20. All called variants were filtered prior to 
phasing by using bcftools version 1.2, which is a part of 
the SAMtools program suite [16]. The applied filters were 
run with the following bcftools command: bcftools filter 
--exclude “QUAL < 30 | NUMALT > = 2 | SAF == 0 | 
SAR == 0 | DP < 10 | DP > 2500 | MAF < 0.01” --SnpGap 
4 --IndelGap 10, which will exclude all variants that do 
not fulfill one of the following criteria: (1) an overall 
quality (QUAL) score less than 30, (2) a total depth with 
less than 10 or more than 2500 reads, (3) if no read was 
observed on either the forward or reverse strand, (4) if 
there was more than one alternate allele, (5) if the minor 
allele frequency was lower than 1  %, (6) if a SNP was 
closer than 4 bp to an INDEL and (7) for any two INDEL 
that were within 10  bp of each other, the lower quality 
INDEL was removed. These filtering criteria are similar 
to those used in the 1000 bull genome project (http://
www.1000bullgenomes.com/), and were chosen to mini-
mize the number of false positive variants, while sacrific-
ing some degree of variant calling sensitivity.
Imputation to full sequence
Genotypes of the called variants were refined and phased 
using Beagle version 4.1 [13]. The initial data input to 
Beagle was the genotype likelihood of each genotype 
reported by Freebayes. The resulting phased dataset was 
then used as a reference panel for imputing all previously 
mentioned 3090 animals to full sequence, ending up with 
a total of 3096 animals with full sequence data and phe-
notypes for CM1. Beagle 4.1 was run with the window 
parameter set to 100,000 SNPs and a window overlap 
set to 10,000 SNPs. Effective population size was set to 
200 and remaining parameters were set to default values. 
Sequence data will be submitted to the European Nucleo-
tide Archive.
Single marker association studies
Single marker analyses were first performed for all 
12 traits and the 26,737 SNPs on BTA6 from the 
high-density BTA6 dataset, and then for the six traits that 
were significant in the first analyses and 65,156 markers 
(SNPs and indels) between 84 and 94 Mb on BTA6.
The initial association analysis of the high-density data-
set was performed with the ASREML package version 2.0 
[18]. The model that was fitted to the information on per-
formance for each trait—marker combination was: 
where DYD is the vector of bull performances weighed 
by the number of daughters, 1 is a vector of ones, μ is 
the overall mean, X is a vector of SNP genotypes coded 
as 0, 1, or 2 depending on the number of copies of the 
first allele, b is the fixed effect of the marker, Z is an inci-
dence matrix relating phenotypes to the corresponding 
random polygenic effects, a is a vector of random poly-
genic effects, and e is a vector of residual effects. Genetic 
and residual variances were estimated from the data. a 
was assumed to follow a normal distribution ~N
(
0,Aσ 2A
)
 
where A is the relationship matrix derived from the 
pedigree, and σ 2A is the additive genetic variance. e was 
assumed to follow a normal distribution ~N
(
0, Iσ 2e
)
 
where σ 2e  is the residual variance. Association analysis 
was performed for each individual marker, and then the 
p value for the marker effect was calculated with the R 
function pf(). The chromosomal Bonferroni corrected 
significance threshold for the HD map was set at [−
log10(0.001/26,737)] = 7.43, corresponding to a nominal 
type I error rate of 0.001 after Bonferroni correction for 
26,737 tests.
For the association analysis of the imputed full 
sequence data, we used the GCTA package (genome-
wide complex trait analysis) with the mixed linear model 
based association analysis (MLMA) option [19] for 
computational efficiency. The model fitted with GCTA 
MLMA is as follows: 
The model description is similar to that used for the 
ASReml analysis, except that DYD is now an unweighted 
vector of bull performances, and g is the random poly-
genic effect, i.e. the accumulated effect of all SNPs as 
captured by the genetic relationship matrix which was 
estimated by GCTA as described by Yang et al. [19]. The 
genetic variance is estimated based on a null model with-
out the marker effect, and then used in the alternative 
model to test for associations between each of the SNPs 
and the trait [19].
Correction for the most significant QTL
In order to determine if more than one QTL segregated 
for any of the six tested traits (i.e., CM1, CM4, CM6, 
kg milk, kg protein and kg fat) the effect of the most 
DYD = 1µ+ Xb+ Za + e,
DYD = 1µ+ Xb+ Zg + e.
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significant marker for CM1 from the single marker analy-
ses was corrected for by including this marker as a cofac-
tor using the mlma-no-adj-covar option in GCTA [19].
Selection of animals with different QTL genotypes
In a preliminary step using only a subset of the 
sequence-level markers, the most significant SNP for 
CM1 was located in intron 1 of GC, i.e. rs110675140 
at 88,728,121  bp (unpublished results). Allele A of 
rs110675140 was associated with increased susceptibility 
to mastitis and also with higher milk yield than allele G. 
Since the imputed full sequence data were not available 
when the analyses of structural variations, mRNA and 
protein analyses were performed, rs110675140 was used 
to select animals that carried the appropriate genotypes 
for these analyses. An LD (r2) of 0.84 was found between 
rs110675140 and the most significant marker for CM1 in 
the full sequence analyses using the Haploview 4.2 soft-
ware [20].
LD measurements
Pair-wise LD measurements (r2) were estimated for all 
pairs of sequence-level markers using the Haploview 4.2 
software [20] on phased data. Haplotypes were defined 
by Haploview according to the confidence intervals strat-
egy [21] or the four gamete rule [22].
Structural variations
Raw data from three bulls that were homozygous AA for 
rs110675140 and five bulls that were homozygous GG 
were merged into one BAM file that included all three 
AA bulls and one BAM file that included all five GG 
bulls using SAMtools [16], which were used to identify 
larger segregating structural variations in the genome 
by the CNV-seq software [23]. Significant results were 
initially examined and visually inspected using the inte-
grative genomics viewer software (IGV [24]), and con-
firmed by PCR on a larger number of animals. PCR 
primers to verify the duplication were designed using 
Primer3 software ver. 4.0.0 [25]. One set of primers 
(5′-GTCTTTCGAACTGCAGGACT-3′ and 5′-TCCC 
ATTGAGCTAAGCCTGG-3′) was designed to amplify a 
221-bp region that spanned from the end of one copy to 
the start of the next copy, while the second primer pair 
(5′-GTCTTTCGAACTGCAGGACT-3′ and 5′-ACTCA 
TGTGTGTTGCCCTCT-3′) was designed to amplify 
a fragment of 370  bp in a non-duplicated region as an 
internal control of the PCR reaction. The PCR reaction 
contained 1  U of Taq polymerase, 10× Taq reaction 
buffer, 1 mM of MgCl2, 0.25 mM of each dNTP, 0.2 pmol/
µL primer “Internal control primer pair”, 0.25 pmol/µL of 
“duplication primer pair” and 20–40 ng of template DNA. 
The reaction conditions included an initial denaturation 
step at 95 °C for 5 min, followed by 35 cycles at 95 °C for 
30 s, 58 °C for 30 s and 72 °C for 1 min, and a final exten-
sion at 72  °C for 10 min. The completed multiplex PCR 
reaction was electrophoresed on a 1  % agarose gel. For 
animals without the duplication, only the internal control 
fragment (370 bp) was amplified, while for animals with 
the duplication in either the homozygous or heterozy-
gous form, both the duplication fragment (221  bp) and 
the internal control band were amplified. The PCR was 
run on 45 NR AI bulls and on 112 liver samples with a 
known genotype at rs110675140. Of these 112 animals, 
23, 47 and 42 animals carried the AA, GG and AG geno-
type, respectively at rs110675140.
Investigations to identify the putative function of the QTL
Several approaches were used to identify the underlying 
causal polymorphism of the QTL. We first checked if the 
significant markers were conserved in mammals using 
the Ensembl database (http://www.ensembl.org). Next, 
the bovine sequence was blasted (http://blast.ncbi.nlm.
nih.gov/Blast.cgi) against the human sequence to iden-
tify possible functional sites (e.g. binding sites for tran-
scription factors, sites affecting alternative splicing, etc.) 
using all available tracks for expression and regulation in 
the UCSC Genome Browser (https://genome.ucsc.edu). 
Finally, putative transcription factor binding sites in the 
bovine sequence were identified using the JASPAR data-
base (http://jaspar.genereg.net/) and Match public ver-
sion 1.0 (http://www.gene-regulation.com/cgi-bin/pub/
programs/match/bin/match.cgi).
Identification and quantification of putative splice variants 
by RNAseq
Differential expression of alternatively spliced variants 
among ten bulls with different genotypes (five AA and 
five GG bulls at rs110675140) was analyzed on mRNA 
isolated from liver samples. These ten bulls were selected 
based on pedigree information to be as unrelated as 
possible, and originated from random farms in order to 
randomize environmental effects. Ten libraries repre-
senting liver samples from the five AA and five GG bulls 
were prepared for sequencing using an Illumina TruSeq 
stranded mRNA LT Set-A kit (Illumina, California, USA) 
with the following slight modifications to the manufac-
turer’s protocol: (i) using 2 µg input RNA, (ii) incubation 
for 25  s (vs. 8  min) at the “elute, fragment and prime” 
step, and (iii) using a cDNA:read ratio of 1:0.7 ratio (vs. 
1:1) (Agencourt AMPure XP Beads; Beckman Coulter, 
California) after adapter ligation and PCR step. Librar-
ies were validated by quantification using a Qubit® 2.0 
Fluorometer and the Qubit® dsDNA BR Assay kit (Inv-
itrogen™, Thermo Fisher, Massachusetts) and by size 
analysis using a 2100 BioAnalyzer system with the DNA 
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High Sensitivity kit (Agilent Technologies, California). 
The mean concentration and length for the libraries were 
40  ng/µL and 700  bp respectively. For normalization, 
the libraries were diluted to 10 nM and pooled in equal 
ratios. Sequencing was performed on a MiSeq (Illumina, 
California) with the 600 cycles MiSeq reagent kit v3 in a 
paired-end mode.
All raw data of reads were formatted as fastq files. 
Before mapping, Illumina adaptors were removed and 
the sequences were quality-trimmed using cutadapt [26]. 
Cutadapt was set to cut adaptors with a minimum over-
lap length of 8 and low-quality 3′ ends were removed by 
setting a quality threshold of 20 (phred quality + 33). An 
index of the bovine UMD 3.1 reference genome was built 
and reads were aligned to the reference genome using 
STAR version 2.3.1 [27]. Sorting, indexing and conver-
sion to the BAM file format (the compressed binary ver-
sion of a SAM file) of the resulting SAM files (sequence 
alignment/map format) were completed by using SAM-
tools version 0.1.19 [16]. Read alignments were assem-
bled to transcripts (NCBI Bos taurus Annotation Release 
104) using Cufflinks version 2.2.1 [28] with a minimum 
isoform fraction set to 1 %. Finally, the R package DEX-
Seq [29] was used to test for differential exon usage 
between GG and AA animals.
Quantification of known alternative spliced variants of the 
GC gene using RT‑qPCR
Results from the RNAseq analyses were confirmed by 
reverse transcription quantitative PCR (RT-qPCR) on 
samples of total liver RNA from ten animals, which were 
the same as those used for RNAseq. The samples repre-
sent technical replicates, i.e. RNA for RT-qPCR and RNA 
for RNAseq were isolated in parallel. Five hundred nano-
gram of total liver RNA was reverse-transcribed using 
the Tetro cDNA synthesis kit (Nordic BioSite, Oslo), the 
cDNA was then diluted and 6.25 ng was used for qPCR. 
qPCR was performed in 20  µL reaction volumes and 
in triplicate per sample using Express SYBR GreenER 
SuperMix with premixed ROX (Invitrogen) according 
to the manufacturer’s recommendations. Transcript lev-
els were analyzed using a 7900HT Fast Real-Time PCR 
System (Applied Biosystems) and the following program: 
95 °C for 2 min, 40 cycles at 95 °C for 15 s and 60 °C for 
1 min, and the melting curve analyses were applied. Prim-
ers specific for the mRNA reference sequence of the Bos 
taurus GC gene (RefSeq; NM_001035380), the predicted 
transcript variant 1 (X1; XM_005208092.1) and the 
predicted transcript variant 2 (X2; XR_234992.1) were 
designed using Primer3 ver. 0.4.0 [25]. Primer sequences 
are in Additional file  2: Table S2. The efficiency of all 
primer pairs was tested by template dilution series and 
reached 81  % for the primers specific to the X2 variant 
and ranged from 90 to 100 % for primers specific to the 
RefSeq and X1 variants. Negative controls with no added 
template were included for all primer pairs (no template 
control), and no RT control reactions for each sample 
and each primer pair were run in qPCR in order to check 
for genomic DNA contamination. Based on the literature 
[30], peptidylprolyl isomerase A (PPIA) was used as ref-
erence gene (control). An initial analysis of the RT-qPCR 
data was performed using RQ Manager 1.2 (Applied Bio-
systems) and a standard deviation of less than or equal 
to 0.3 per triplicate was accepted. The ΔCt method was 
used for the statistical analysis of the RT-qPCR data, i.e. 
ΔCt  =  Cttarget  −  Ctcontrol, and normalized gene expres-
sion was calculated as 2(−ΔCt). The differences between 
transcript levels in animals with different genotypes, and 
between the three transcript variants, were tested using 
a t test.
Protein concentrations and ligand binding
Serum concentrations of several proteins in 50 NR cows 
(15 with genotype AA and 35 with genotype GG at 
rs110675140) were estimated as follows: DBP concen-
trations were determined by Vitas-Analytical Services 
(Oslo, Norway) using an enzyme-linked immunosorb-
ent assay (ELISA kit; Antibodies-online GmbH, Aachen) 
according to the manufacturer’s instructions. Absorb-
ance was detected at 450  nm. Albumin (ALB) con-
centrations were determined by The Central Clinical 
Laboratory (Sentralaboratoriet, NMBU School of Vet-
erinary Medicine, Oslo) with the bromocresol green 
(BCG) dye-binding method (Advia 1800 Chemistry Sys-
tem, Siemens Healthcare, Germany). Serum albumin 
quantitatively binds to BCG to form an albumin-BCG 
complex that was measured as an endpoint reaction at 
596 nm. 25-Hydroxy-vitamin D [25(OH)D2 and 25(OH)
D3] concentrations were determined by applying a liq-
uid chromatography–tandem mass spectrometry (LC–
MS/MS) method developed at the Hormone laboratory 
(Oslo University Hospital). More details on these proce-
dures are in Additional file 3. Free, bioavailable, ALB- and 
DBP-bound 25(OH)D2, 25(OH)D3 and total 25(OH)D [a 
sum of 25(OH)D2 and 25(OH)D3] were calculated using 
modified equations previously described in [31, 32], 
based on the serum concentrations of 25(OH)D, DBP and 
ALB. Briefly, this method defines the bioavailable vita-
min D as the fraction that is both free and ALB-bound, 
i.e. not bound to DBP. For this calculation, the human 
affinity-binding constants for 25(OH)D interaction with 
DBP and ALB described in [33] were used. General lin-
ear model (GLM) analyses in SAS 9.2 (SAS Institute Inc., 
Cary, NC) were used to determine possible effects of the 
rs110675140 genotype on the concentrations of DBP, 
ALB, 25(OH)D2, 25(OH)D3 and total 25(OH)D; free 
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25(OH)D2, 25(OH)D3 and total 25(OH)D; bioavailable 
(i.e., free and ALB-bound) 25(OH)D2, 25(OH)D3 and 
total 25(OH)D; DBP-bound total 25(OH)D; and ALB-
bound total 25(OH)D in the serum. The model included 
three fixed effects, i.e. rs110675140 genotype (two 
classes, AA and GG), lactation number (five classes), and 
stage of lactation at the time of sampling (months after 
calving, six classes) as explanatory variables. The general 
linear model analyses were performed with and without 
nine heifers that had not had their first calf at the time of 
sampling.
Results and discussion
Association analyses of mastitis and milk production traits 
with the high‑density SNP set on BTA6
Single marker association analyses were performed for 
all seven CM traits and five milk production traits and 
~27,000 SNPs on BTA6. Highly significant results were 
detected for CM1, CM4, CM6, kg milk, kg protein, kg 
fat and protein percentage in a region between ~88.7 
and 88.9  Mb on BTA6 (Table  1). The strongest asso-
ciation was observed between CM1 and rs110300280 at 
88,744,593 bp. This marker was also the most significant 
marker for CM4 and kg milk. No significant associations 
were found for CM2, CM3, CM5 and CM7 on BTA6. As 
examples, results for CM1, kg milk, kg protein and kg fat 
are in Fig. 1, and complete results for all traits and SNPs 
are in Additional file 4: Table S3.
The most significant SNP in this analysis, rs110300280, 
was located approximately 5400 bp 5′ from the transcrip-
tion start site of the GC gene. GC is transcribed on the 
reverse strand between 88.74 and 88.69 Mb (according to 
the UMD 3.1 assembly of the bovine genome) and is the 
only known gene in close vicinity of this QTL position. 
The closest genes on either side are SLC4A4 [solute car-
rier family 4 (sodium bicarbonate cotransporter), mem-
ber 4] at ~88.2–88.5  Mb and NPFFR2 (neuropeptide FF 
receptor 2) at ~89  Mb, but the significance levels of all 
traits were markedly reduced for SNPs within and closer 
to these genes, and hence our analyses indicate GC as the 
strongest positional candidate gene for the QTL.
Association analysis of mastitis and milk production on full 
sequence data
The traits CM1, CM4, CM6, kg milk, kg protein and kg 
fat were reanalyzed for a total of 65,156 SNPs between 
84 and 94  Mb on BTA6 that were detected by whole-
genome resequencing. All detected sequence level vari-
ations within the GC gene as well as within a flanking 
region of ~5 Mb on each side of the gene were analyzed 
in order to verify that GC was the causal gene and, if pos-
sible, identify the causal variations within this gene. For 
computational reasons, the analyses were performed 
with a different software than in the previous step. The 
p values were lower in this step than in the previous one, 
most likely due to differences in the algorithms used.
For all traits tested, a series of SNPs with very similar 
p values were detected within and close to GC (Fig.  2; 
Table  2). They were all located either in introns of the 
GC gene or immediately before the gene on the 5′ end, 
and showed markedly higher significance levels than all 
SNPs in the coding regions. The ranking of the SNPs dif-
fered somewhat among the traits (Table  2). CM1 and 
kg milk were most strongly associated to rs110483492 
at 88,741,762  bp [−log10(p value)  =  11.52 and 12.75, 
respectively], which is located ~2.5  kb 5′ of the tran-
scription start site. The G allele of rs110483492 was 
associated to higher mastitis incidence and higher milk 
yield than the A allele, and showed a frequency of ~34 % 
among the genotyped bulls. Nearly similar significant p 
values were found for several other SNPs in intron 1 of 
GC and immediately upstream of the gene. kg fat was 
most significantly associated to rs381872595 [−log10(p 
value) = 7.76], an indel at ~88,743,767 bp that was also 
among the most significant markers for CM1 and kg 
milk. kg protein, CM4 and CM6 showed the strongest 
Table 1 Results from association analyses for the SNPs on BTA6 from the Illumina BovineHD BeadChip
For each trait, the most significant SNP for the QTL that was detected close to the GC gene is shown with its position in base pairs (bp), negative logarithm of the p 
value [−log(p)], minor allele frequency (Freq), allele substitution effect for the first allele of the SNP (Effect), standard error of the SNP effect (SE), and alleles
a CM1, CM4 and CM6: clinical mastitis in the period from −15 to 30 days postpartum in the first, second and third lactations, respectively. Performance data for kg 
milk, kg protein and kg fat refers to 305 d lactation yields
Traita SNP bp −log(p) Frequency Effect SE A1 A2
CM1 rs110300280 88,744,593 18.1 0.37 0.007 0.0008 A G
CM4 rs110300280 88,744,593 11.9 0.37 0.006 0.0008 A G
CM6 rs109066341 88,890,502 11.5 0.41 0.007 0.001 G A
kg milk rs110300280 88,744,593 11.4 0.37 46.07 6.619 A G
kg protein rs134055603 88,832,335 17.7 0.42 1.65 0.187 A G
kg fat rs110679276 88,750,266 9.6 0.38 1.70 0.2669 A G
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Fig. 1 Results for single‑marker association analysis of CM1, kg milk, kg protein and kg fat on the high‑density map for BTA6. Top Results for all 
tested SNPs on BTA6. −log10(p value) on the y-axis and marker position in Mb on the x-axis. Bottom Zoom on the region between 88.0 and 89.7 Mb. 
Gene positions are indicated with grey rectangles
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Fig. 2 Results for single‑marker association analyses of CM1 using imputed full sequence data. Top Results for all tested SNPs. Bottom Zoom on the 
region between 88.6 and 89.2 Mb. Gene positions are indicated with grey rectangles. The most significant marker, rs110483492 at 88,741,762 bp, is 
highlighted in green
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associations with markers at ~88.9 Mb and with markers 
within and immediately close to GC. Results for all traits 
and markers are in Additional file 5: Table S4. However, 
as shown in Fig. 2, the significance levels decreased only 
moderately from GC towards ADAMTS3, and the possi-
bility that the QTL effect is due to polymorphisms closer 
to NPFFR2 or ADAMTS3 could not be completely ruled 
out. On the other hand, none of the markers in the cod-
ing or promoter sequences of these genes were among 
the most significant.
The more telomeric positions of the most significant 
markers for kg protein, CM4 and CM6 could suggest that 
additional polymorphisms affected these traits. However, 
when the effect of rs110483492 at 88,741,762 bp was cor-
rected for, no markers remained significant for any of the 
six traits. Hence, all significant markers are most likely in 
strong LD with the same causal polymorphism.
The use of full sequence data did not refine the QTL 
region much more compared to the first step. However, 
since the sequence data include all the variants that are 
present in a larger region, other genes than GC could be 
excluded as causal. Moreover, the analysis suggests that 
the underlying causal variation has a regulatory role since 
no variants within the coding sequences were among the 
most significant ones.
LD structure
LD analyses revealed a relative complex LD structure, 
which reflects the history of the NR breed. Highly signifi-
cant SNPs were located in a larger region that spanned 
the entire GC gene and several kb from its 5′ end, and 
were dispersed in-between other SNPs that had much 
lower significance levels. All the SNPs with a p value 
lower than 1*e−11 for CM1 were in high LD with each 
other, most often with an r2 higher than 0.95. One unex-
pected exception was the most significant SNP for CM1 
at 88,741,762 bp, which showed an r2 with the other top 
SNPs of ~0.84. The top-ranking SNPs were distributed 
across a large number of haplotype blocks, and most 
blocks contained SNPs with highly variable significance 
levels. For CM1, most of the SNPs with a p value lower 
than 1*e−12 were in three blocks that covered the region 
between 88,739,045 and 88,744,985 bp, i.e., a region that 
spanned from the beginning of intron 1 to ~5 kb from the 
transcription start site. For each of these SNPs, the allele 
that was associated with the highest mastitis incidence 
and milk yield was unique to a haplotype with a fre-
quency of 37 %, which is in agreement with the frequency 
of the individual alleles.
Such an LD pattern that consists of a high LD between 
rather distant SNPs, which are interspersed in-between 
many other SNPs with a much lower LD is typical for 
most commercial cattle breeds that have undergone a 
rapid recent decrease in effective population size from 
a large ancestral population due to selection and breed 
formation. The long-ranging LD is most likely due to 
the presence of some long haplotypes that are the result 
of the recent extensive use of AI bulls and that have not 
been broken apart by recombination, in a background 
of much shorter haplotypes that reflect the large ances-
tral population. The size and the combinational effects 
of such haplotypes limit our ability to fine map and pre-
cisely identify the causal polymorphism(s) that underlie 
the QTL based only on association mapping results.
Structural variation
A search for larger structural variants in resequencing 
data from 21 NR sires revealed a marked increase in read 
depth for a 11,781-bp region between 88,693,550 and 
88,681,769 bp (i.e., 2.4 kb 3′ of the last ordinary exon of 
GC, see below) for animals that are homozygous AA at 
rs110675140 (Fig.  3). This increase was not present in 
the homozygous GG animals, while for the heterozy-
gous GA animals an intermediate increase in read depth 
was observed (Fig. 3). This indicates that the sequence is 
duplicated in the haplotypes that carry the A allele, but 
not in those that carry the G allele. The orientation of the 
paired end reads that span the breakpoint of the duplica-
tion suggested that the two copies of the sequence were 
orientated as a tandem duplication.
Table 2 Results from association analyses of SNPs in the candidate gene region
The most significant SNP for each of the traits is shown with its position in base pairs (bp), negative logarithm of the p value [−log(p)], minor allele frequency (Freq), 
allele substitution effect for the first allele of the SNP (Effect), standard error of the SNP effect (SE), and alleles
a CM1, CM4 and CM6: clinical mastitis in the period from −15 to 30 days postpartum in first, second and third lactation, respectively
Traita SNP bp −log(p) Freq Effect SE A1 A2
CM1 rs110483492 88,741,762 11.5 0.34 0.007 0.001 G A
CM4 rs208489948 88,808,884 7.0 0.34 0.005 0.001 T C
CM6 rs109133718 89,069,508 9.1 0.36 0.008 0.001 C T
kg milk rs110483492 88,741,762 12.8 0.34 60.8 8.26 G A
kg protein rs385796667 88,804,540 12.8 0.39 1.73 0.23 G A
kg fat rs381872595 88,743,767 7.8 0.36 1.91 0.34 Del Ins
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The presence and the orientation of the duplication 
were verified by PCR on DNA from 45 AI bulls and 
112 randomly selected abattoir samples, and compared 
against rs110675140 genotypes. Bands that confirmed 
the duplication were observed for all 37 animals with 
genotype AA at rs110675140, and for 57 of the 58 ani-
mals with genotype GA (see Fig.  4 for examples). The 
duplication was absent in 60 of the 62 animals with 
genotype GG and very weak bands were observed for the 
two remaining GG animals. Thus, this duplication segre-
gated almost perfectly with the alleles at rs110675140 in 
the NR population.
We aligned the entire sequence of the duplication 
against the human genome in order to search for con-
served functional elements. The duplicated region 
overlapped the position of the alternative last exon 
Fig. 3 Visualization of the duplication. The first animal, 10177, is homozygous AA at rs110675140 and shows an increased read depth in a region 3′ 
of GC. This indicates that the region is duplicated. Moreover, the duplication is found in both haplotypes since the read depth is doubled compared 
to the surrounding regions. The second animal, 3718, is heterozygous GA, and has an intermediate read depth. This indicates that the duplication 
is present in one haplotype only (i.e., the one that also carries allele A). The last animal, 10540, is homozygous GG at rs110675140, and has a normal 
read depth, which indicates that there is no duplication
Fig. 4 Verification of the duplication by PCR in animals with different genotypes at rs110675140. The upper band (370 bp) is an internal control that 
is amplified in all animals, while the lower band (221 bp) is the fragment that is amplified in animals carrying the duplication. GA, GG, and AA are the 
genotypes of the animals at rs110675140. Lane 10 is a negative control, L is the 500 bp reference ladder
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13 found in the predicted GC transcript variant X1 
(XM_005208092.1), thus one possibility is that the pres-
ence of two copies of this exon may affect the level, sta-
bility or function of this transcript. A study that mapped 
regions enriched for acetylated lysine 27 on histone H3 
(H3K27ac) via chromatin immunoprecipitation followed 
by high-throughput sequencing (ChIP-seq) showed that 
binding sites for enhancers were situated within the 
duplicated region (http://nagrp.ansci.iastate.edu/eric/
epidb/rsem_expression.php#type1chipseq). Having two 
copies of this site could, in theory, affect transcription of 
GC.
The DNA sequence of the duplicated region showed 
remarkably little variation, since only 19 SNPs were 
detected in the entire ~12 kb region. None of the mark-
ers within or near the duplication were among the most 
significant for any of the traits.
Putative function of the QTL
Since none of the markers in the coding regions were 
among the most significant, the causal polymorphism 
was expected to have a regulatory role. The GC gene is 
mainly transcribed in the liver [11]. Liver-specific GC 
expression in humans and rat was shown to be regu-
lated through binding sites for the hepatocyte nuclear 
factor 1 (HNF1) that are situated 5′ of the transcrip-
tion start site [34, 35], and through additional sites for 
the CCAAT/enhancer binding protein (C/EBP) that are 
located in intron 1 in humans [34]. First, we searched 
publicly available databases for putative HNF1 and C/
EBP binding sites in the bovine sequence. The most 
likely HNF1 site was found between 88,739,350 and 
88,739,364 bp on BTA6. This region is confirmed by the 
UCSC Genome Browser (https://genome.ucsc.edu), 
which reports a conserved HNF1 site 5′ of the human 
GC gene in a region that aligns to around 88,739,350 bp 
in the bovine sequence. This site is located near three of 
the most significant SNPs for CM1, i.e. rs109360654 at 
88,739,045  bp (intron 1), rs108964685 at 88,739,413  bp 
(5′ region) and rs109541079 at 88,739,458 bp (5′ region). 
The most likely binding sites for C/EBP were found 
in the region between 88,727,907 and 88,727,918  bp, 
which is between rs109056048 at 88,727,480  bp and 
rs110675140 at 88,728,121  bp in intron 1. The human 
GC gene may also be regulated via two binding sites for 
the CCCTC-binding factor (zinc finger protein) (CTCF; 
http://ensembl.org). The sequences of these two sites 
align to regions that overlap the SNPs rs109056048 at 
88,727,480 bp and rs109360654 at 88,739,045 bp, respec-
tively. When searching the sequence that surrounds the 
most significant SNP for CM1 at 88,741,762 bp for puta-
tive transcription factor binding sites using the JASPAR 
database, putative binding sites for different members 
of the C/EBP family were detected in regions between 
88,741,755 and 88,741,765  bp and between 88,741,764 
and 88,741,773 bp, respectively.
Characterization and quantification of GC transcripts
Studies on the gene expression of GC in cattle show that 
it is predominantly expressed in liver, with no expres-
sion in the mammary gland (http://www.bovinegenome.
org, http://nagrp.ansci.iastate.edu/eric/epidb/index.php, 
unpublished results in Norwegian Red cattle). To inves-
tigate if the QTL effect was due to differences in alterna-
tive splicing or expression levels of the GC mRNA, we 
tested liver samples from ten healthy individuals with 
different genotypes at rs110675140 (five AA and five GG 
animals). Results from RNAseq showed that all animals 
carried three transcripts with no significant difference 
between genotypes (not shown), i.e. the RefSeq transcript 
(NM_001035380.2) that consists of exons 1–13, the pre-
dicted transcript variant X1 (XM_005208092.1) in which 
exon 13 is replaced by an alternative last exon, and tran-
script variant X2 (XR_234992.1), which is similar to the 
RefSeq transcript except that it contains an additional 
small exon between exons 12 and 13 (Fig.  5). No other 
transcripts were detected. We detected several SNPs and 
short indels in the GC RNA sequences, but none of these 
segregated with the alleles at rs110675140. In the next 
step, the results from RNAseq were confirmed using RT-
qPCR. Again, the same three transcripts were found in 
all tested animals (not shown), with no significant differ-
ence between genotypes (p > 0.05, Fig. 6). The level of the 
NM_001035380.2 transcript was higher than the levels of 
the less common X1 and X2 variants (p ≤ 0.001).
Although the DNA sequence showed that the alterna-
tive exon 13 was duplicated in animals with allele A at 
rs110675140, there was no evidence of expression of the 
duplication in the form of mRNA in the liver samples of 
any animal. Hence, we could not detect any effect of the 
duplication on the transcript levels under the examined 
conditions.
Protein concentrations and vitamin D binding
The vitamin D-binding protein (DBP) encoded by the GC 
gene is the main carrier of vitamin D and its metabolites 
in serum. Vitamin D exists in two distinct forms: cutane-
ously-derived vitamin D3 and plant-derived vitamin D2. 
Both forms are metabolized in the liver into the major cir-
culating metabolites, 25(OH)D3 and 25(OH)D2, respec-
tively [36, 37]. Serum concentration of total 25(OH)D is 
considered to be a reliable marker for vitamin D status. In 
the kidney, 25(OH)D is further metabolized into the active 
hormone 1,25-dihydroxyvitamin D (see Additional file 3: 
Figure S1), with strictly regulated levels. We determined 
the concentrations of DBP, free vitamin D, DBP-bound 
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vitamin D and related factors in serum, and tested for 
differences among animals with different genotypes at 
rs110675140. However, the GLM analyses showed no sig-
nificant effect of the genotype at rs110675140 (p > 0.05) 
on any of the variables except for ALB (p =  0.04), with 
homozygous GG animals having higher ALB concentra-
tions than homozygous AA animals [LSMEANS 36.2 vs. 
34.1, (see Additional file 6: Table S4)].
Stage of lactation had a significant effect (p < 0.01) on 
the concentrations of DBP, 25(OH)D2, 25(OH)D3, free 
25(OH)D2 and bioavailable 25(OH)D2. Concentrations 
of DBP and 25(OH)D3 increased while that of 25(OH)D2 
decreased as lactation progressed. Concentrations of free 
25(OH)D2 and bioavailable 25(OH)D2 were highest dur-
ing the first month after calving and decreased thereafter. 
This is consistent with previous studies in humans [38, 
39]. In cattle, 25(OH)D3 concentrations are reported to 
be associated with the pregnancy cycle and the lactation 
stage, with the highest 25(OH)D3 serum concentration 
observed during mid lactation [40]. Our study reports 
for the first time an association between the serum DBP 
concentrations and the lactation stage in dairy cattle. See 
(Additional file 6: Table S5) for more details.
Evidence that supports GC as the positional and functional 
candidate gene for the QTL
Although high LD and long-range haplotypes in the QTL 
region complicate fine mapping and make it impossi-
ble to identify a causal polymorphism for the QTL, the 
results strongly support GC as the best positional candi-
date gene and agrees with results from other studies e.g. 
[6–10]. Sahana et al. [9] used whole-genome resequenc-
ing data to position the QTL for CM within a region that 
contains only two genes, GC and NPFFR2. They reported 
slightly different positions for this QTL in the two 
Fig. 5 Expression of the differentially spliced GC mRNAs obtained from DEXSeq. Blue and red lines show expression of each exon in homozygous 
AA and GG animals at rs110675140, respectively. Exons included in the three transcripts are shown below. All: all identified exons. XM_005208092.1: 
exons in predicted transcript variant X1 (XM_005208092.1). XR_234992.1: exons in predicted transcript variant X2 (XR_234992.1), NM_001035380.2: 
exons in RefSeq transcript (NM_001035380.2)
Fig. 6 Transcript levels of homozygous AA and GG animals for the 
three detected GC transcripts obtained by RT‑qPCR. AA and GG are 
the genotypes of the animals at rs110675140
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analyzed breeds, with the most significant SNPs located 
at 88.72  Mb (intron 1 of GC) in Nordic Red cattle, and 
at 88.97 Mb in Nordic Holstein. High LD in this region 
limited their ability to identify the causal polymorphism. 
The authors also tested for co-segregation with milk pro-
duction traits in their Danish Holstein population and 
detected significant associations for kg milk, kg protein 
and kg fat between ~88.5 and 89.5  Mb [9], which is in 
agreement with our study.
In a follow-up study on Danish Holstein cattle, asso-
ciations with CM were observed at three different loca-
tions in the region between 88.06 and 89.07 Mb [41]. One 
QTL overlapped with the deoxycytidine kinase (DCK) 
gene, the second overlapped with the solute carrier fam-
ily 4, sodium bicarbonate co-transporter, and member 4 
(SLC4A4) gene, and the last QTL overlapped with the 
neuropeptide FF receptor 2 (NPFFR2) gene. No signifi-
cant QTL within or near the GC gene were detected in 
Danish Holstein, which may indicate that different poly-
morphisms affect susceptibility to CM in Holstein as 
compared to Nordic and Norwegian Red breeds. How-
ever, the LD between the SNPs in the third QTL (i.e. at 
NPFFR2) and the most significant SNPs in our study was 
high (not shown), and indicates that this third QTL in 
Danish Holstein is the same as the QTL detected in Nor-
dic Red and Norwegian Red.
In addition, Goddard et  al. [10] reported GC as the 
gene that underlies a QTL for milk production in an 
Australian Holstein population. Again, in this study, the 
high LD in the QTL region made it difficult to pinpoint 
a causal polymorphism. However, they identified the 
most significant SNPs at 88,741,762 and 88,743,767  bp 
depending on the methods. These SNPs are the most sig-
nificant and third most significant SNPs for CM1 in our 
study, and among the most significant for the remaining 
traits.
Group-specific component encodes DBP, which has 
multiple important biological roles in the immune sys-
tem and host defense. DBP is the major plasma protein 
carrier of vitamin D3 and its metabolites. Vitamin D3 has 
a function as a cytokine that is generated to protect the 
host against microbial invaders [42]. During an infection, 
both human and bovine monocytes and macrophages 
express an enzyme that converts vitamin D into its bio-
logically active form [43–45], which then regulates the 
expression of the vitamin D responsive genes [46]. Recent 
studies indicate that vitamin D signaling has important 
roles in the immune function and infectious disease 
resistance in cattle [44, 45, 47], and DBP was found to 
be a serum biomarker during subclinical mycobacterial 
infections in cattle [48].
Vitamin D-binding protein was also suggested to be a 
precursor of the macrophage activating factor Gc-MAF 
[49]. Activated macrophages develop the capacity for 
specialized tasks such as chemotaxis, phagocytosis and 
the lysis of intracellular parasites, as well as the destruc-
tion of tumor cells [50]. Furthermore, DBP was shown to 
increase monocyte and neutrophil chemotaxis to com-
plement component C5a (C5a)-derived peptides [51, 52].
DBP may have a direct effect on milk production. God-
dard et al. [10] suggested that this effect could be medi-
ated through the number and activity of mammary 
epithelial cells, since vitamin D restricts growth and dif-
ferentiation of these cells in tissue culture [53–55]. Vita-
min D also has a key function in maintaining serum levels 
of calcium by stimulating intestinal calcium absorption, 
mobilization of calcium from bone and stimulating the 
renal reabsorption at the onset of lactation, when large 
amounts of calcium are secreted into the milk and colos-
trum [56]. The association that we detected between 
serum DBP and vitamin D concentrations with lactation 
stage also suggests a role of DBP and vitamin D in regu-
lating milk production in dairy cattle.
Hence, the QTL could either affect host immune 
response to pathogens and indirectly decrease milk pro-
duction in diseased animals, or the main effect could be 
on increased milk production with a secondary effect on 
mastitis, for instance due to lack of energy for immune 
defense or strain on the teat canal and sphincter muscle 
from increased volume at each milking. Alternatively, 
the mechanisms behind milk production and immune 
response could be affected more or less independently by 
the same underlying polymorphism, or by multiple poly-
morphisms in high LD with each other.
In this study, we did not succeed in identifying the func-
tional variant that is responsible for the QTL. A limitation 
of our study was the choice of the animals used for RNA 
expression and protein analyses. Ideally, such analyses 
should use samples from cows with different genotypes 
during a mastitis infection. However, sampling such mate-
rial with uniform quality and in sufficiently large amounts 
for proper statistical analysis poses a rather complicated 
logistics challenge, at least in Norway where the farms are 
small and situated far apart, and would need a long period 
of time. This was beyond the duration and resources 
of this project, and analyses were therefore restricted 
to material that was readily available. RNA expression 
was analyzed in liver samples, since the GC gene is most 
highly expressed in this tissue [11]. However, most of the 
available samples were from healthy bulls, and the QTL 
seems to show functional significance only in females or 
during an infection. Protein analyses were performed in 
serum samples from cows, but these were also healthy 
animals. A more successful strategy to identify the nature 
of the QTL might be to investigate RNA expression and 
protein levels in cows with mastitis.
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Conclusions
Association analysis of full sequence data mapped a 
highly significant QTL that affects both clinical mas-
titis in early lactation and milk production to a region 
within or immediately upstream of the GC gene. We 
also detected a duplication downstream of the GC gene 
that segregated with the alleles of this QTL. The duplica-
tion covered the alternative last exon of the GC gene and 
might contain binding sites for enhancers. No differences 
neither in GC transcript levels nor in protein levels and 
binding were detected under the examined conditions, 
but our data did not permit any final conclusions to be 
drawn on differences in transcription or protein binding 
during an infection. Further functional studies including 
both healthy and infected animals are needed to reveal 
the causative variants that underlie this QTL.
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